Effects of metoprolol and amiodarone combination on heart rate, myocardial contractility and coronary flow: Study in isolated perfused rat hearts

Experimental and Clinical Cardiology

Volumn 9, Issue 2, 2004, Pages 133-137

  Pádua Filho, Wagner ^a   Brasil, David P ^a   Neves, Hueverson J ^b   Gomes, Otoni M ^b   Bocchi, Edimar A ^c  

^a Medical Science Faculty of Minas Gerais   (Brazil)

^b ServCor   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amiodarone; Coronary flow; Heart rate; Langendorff technique; Metoprolol; Myocardial contractility

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CHRONOTROPISM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG CROSS REACTIVITY; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEART PROARRHYTHMIA; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; RAT STRAIN; SYSTOLIC BLOOD PRESSURE; TOXICITY TESTING;

EID: 4444383979     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Disease, 6th edn. Philadelphia: WB Saunders Company, 2001.
2. Waagstein F, Bristow MR, Swedberg K, et al, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial study group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
4. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 1970;39:657-67.
5. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-34.
6. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-8.
7. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
8. Krum H, Shusterman N, MacMahon S, Sharpe N. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zeland Heart Failure Research Collaborative Group. J Card Fail 1998;4:281-8.
9. Macdonald PS, Keogh AM, Aboyoun C, Lund M, Amor R, McCaffrey D. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure. Heart 1999;82:589-93.
10. Julian DG, Camm AJ, Frangin G, et al, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74. (Errata in Lancet 1997;349:1180,1776)
11. Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.
12. Colégio Brasileiro de Experimentação Animal (COBEA). Princípios acEticos na Experimentação Animal. São Paulo: Colégio Brasileiro de Experimentaçã o Animal, 1991.
13. Langendorff O. Untersuchungen am uberlebenden sangethierherzen. Pflugers Arch 1895;61:291-332. Apud in: Doring HJ, Dehnert H, eds. The isolated perfused warm-blooded heart according to Langendorff. In: Methods in Experimental Physiology and Pharmacology, English edn. Berlin: Biomesstechnik-Verlag, 1988.
14. Sufherland FJ, Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000;41:613-27.
15. Takala TE, Hassinen IE. Effect of mechanical work load on the transmural distribution of glucose uptake in the isolated perfused rat heart, studied by regional deoxyglucose trapping. Circ Res 1981;49:62-9.
16. de Leiris J, Harding DP, Pestre S. The isolated perfused rat heart: A model for studying myocardial hypoxia or ischaemia. Basic Res Cardiol 1984;79:313-21.
17. Krebs HA, Henseleit K. Untersuchungen over die hanstoffbildung in tierkorper. Hope scylersz. Phisiol Chem 1932;210:33-66. Apud in: Doring HJ, Dehnert H, eds. The isolated perfused warm-blooded heart according to Langendorff. In: Methods in Experimental Physiology and Pharmacology, English edn. Berlin: Biomesstechnik-Verlag, 1988.
18. Maues HK, Padua-Filho WC, Faraj M, Neves HJ, Gomes ES, Gomes OM. Atenolol and fentanyl effects upon heart rate, myocardial contractility and coronary flow in isolated rat hearts. J Mol Cell Cardiol 2001;33:A75. (Abst)
19. Moraes AAP, Padua-Filho WC, Faraj M, Gomes ES, Neves HJ, Gomes OM. Effect of diazepam and amiodarone on the myocardium contractility response: Experimental study in isolated rat hearts. J Mol Cell Cardiol 2001;33:A78. (Abst)
20. Carvalho AM, Padua-Filho WC, Faraj M, Gomes OM. Amiodarone-fentanyl association effect on the myocardial contractility, heart rate and coronary flow: Study in isolated rat heart. J Mol Cell Cardiol 2001;33:A18. (Abst)
21. Guyton A, Hall JE, eds. Tratado de Fisiologia Médica, 9th edn. Madrid: McGraw-Hill, 1997:107.
22. Gottlieb R, Magnus R. Digitalis und Herzarbeit. Nach Versuchen am uberlebenden Warmbluterherzen. Naunyn Schmeidebergs Arch Exper Path Und Pharmakol 1904;51:30.
23. Friberg P, Nordlander M. Influence of long-term antihypertensive therapy on cardiac function, coronary flow and myocardial oxygen consumption in spontaneously hypertensive rats. J Hypertens 1986;4:165-73.
24. Gordeladze JO, Sellevold OFM, Jynge P. Beta-adrenergic signalling and threshold adrenaline concentration for induction of fibrillation in the perfused heart pretreated with antihypertensive drugs. Res Exp Med (Berl) 1999;199:129-40.
25. Nakasone J, Kato T, Noguchi K, Nagamine F, Sakanashi M. Effects of atenolol and some others beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts. Jpn J Pharmacol 1988;47:387-95.
26. Stark G, Windisch M, Haller EM, et al. Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig hearts. Cardiovasc Res 1991;25:807-14.
27. Milliken GA, Johnson DE. Analysis of Messy Data. New York: Van Nostrand Reinhold, 1984.
28. Conover WJ. Practical Nonparametric Statistics. New York: John Wiley & Sons, 1980.
29. Leor J, Levartowsky D, Sharon C, Farfel Z. Amiodarone and beta-adrenergic blockers: An interaction with metoprolol but not with atenolol. Am Heart J 1988;116:206-7.
30. Derrida JP, Ollagnier J, Benaim R, Haiat R, Chiche P. [Amiodarone and propranolol: A dangerous combination?]. Nouv Presse Med 1979;8:1429.
31. Tosaki A, Szekeres L, Hearse DJ. Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: Protection is secondary to bradycardia. J Cardiovasc Pharmacol 1987;10:489-97.
32. Hearse DJ, Crome R, Yellon DM, Wyse R. Metabolic and flow correlates of myocardial ischaemia. Cardiovasc Res 1983;17:452-8.
33. Liu XK, Engelman RM, Agrawal HR, Das DK. Preservation of membrane phospolipids by propranolol, pindolol and metoprolol: A novel mechanism of action of beta-blockers. J Mol Cell Cardiol 1991;23:1091-100.
34. Nokin P, Jungbluth L, Mouton J. Protective effects of amiodarone pretreatment on mitochondrial function and high energy phosphates in ischaemic rat heart. J Mol Cell Cardiol 1987;19:603-14.
35. Kojima S, Wu ST, Wikman-Coffelt J, Parmley WW. Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts. J Pharmacol Exp Ther 1995;275:254-62.
36. Bashir Y, Paul VE, Griffith MJ, et al. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function. Am Heart J 1992;124:1233-40.
37. Tonet J, Frank R, Fontaine G, Grosgogeat Y. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. Pacing Clin Electrophysiol 1988;11:1984-9.